Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1 Neoplasms 1 Lung Neoplasms 1

Interventions

Cyclophosphamide 14 Temozolomide 10 Magnetic Resonance Spectroscopy 10 dinutuximab 9 Biopsy 9 X-Rays 8 Specimen Handling 8 Irinotecan 8 Phantoms, Imaging 7 fludarabine 6 Topotecan 6 Nuclear Medicine Department, Hospital 6 Vincristine 5 3-Iodobenzylguanidine 5 sargramostim 4 fludarabine phosphate 4 Melphalan 4 Isotretinoin 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Etoposide 4 tipifarnib 3 Radiotherapy 3 Filgrastim 3 Doxorubicin 3 Colony-Stimulating Factors 3 Carboplatin 3 ulixertinib 2 tazemetostat 2 selpercatinib 2 saponin QA-21V1 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × Pregnancy Tests × 90 days × Clear all

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡